Copeptin – the better vasopressin
Because of technical limitations of AVP assays, vasopressin concentrations were rarely measured in the past. The vasopressin surrogate Copeptin now opens the possibility
to take full advantage of the hormone’s diagnostic potential. Copeptin is routinely measured for differentiate all forms of diabetes insipidus from primary polydipsia with an easy to use assay technology at highest sensitivity and stability.
Copeptin – Safe AMI Rule-Out on admission with the 1st blood draw. Now recommended in the 2015 ESC Guidelines.
In this era of overcrowded emergency departments (EDs), measuring Copeptin along with Troponin (Tn) in the first blood draw now is proven to safely increase ED discharge, and significantly decrease hospital and ED/chest pain unit (CPU) lengths-of-stay, in patients presenting with signs and symptoms of Acute Coronary Syndrome (ACS).